OS updates for Imagyn50

from Listen to Gynecologic Oncology · host Health Advance

Editor’s Choice: Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancerHosted by:Ursula Matulonis, MD, Associate Editor of Gynecologic OncologyFeaturing:Kathleen N. Moore, MD, GOG-F and Stephenson Cancer Center at the University of Oklahoma Health Sciences Center Check out more content on the journal's homepage at https://www.gynecologiconcology-online.net

Episode metadata supplied by the publisher feed · Published Nov 1, 2023

Embed this episode

Attribution link and audio player

Ready to play

OS updates for Imagyn50

0:00 14:03

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to Gynecologic Oncology?

This episode is 14 minutes long.

When was this Listen to Gynecologic Oncology episode published?

This episode was published on November 1, 2023.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Listen to Gynecologic Oncology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!